Login to Your Account

FDA Adcom: 'No Limits' on New Tumor Cell Lines in Vaccines

By Catherine Shaffer
Staff Writer

Wednesday, September 19, 2012
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) found no red flags preventing the use of new tumorigenic cell lines for vaccine production, but had plenty of questions and hypotheticals for the experts gathered at Wednesday's meeting.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription